. Using the techniques of partial N-terminal, amino acid sequencing and highpressure liquid chromatography (HPLC) tryptic peptide mapping, we have shown that the E, polypeptides have striking homology with human p34 chains, at least at their N-termini; that the E~ and E k polypeptides are very similar, if not identical; that the A,,, A#, and E~ polypeptides of various haplotypes differ by multiple amino acid substitutions; and that the genes encoding these proteins map to the H-2 complex (16) (17) (18) (19) (20) .
Two-dimensional electrophoretic analyses of Ia immunoprecipitates by Jones et al. (21) have shown that a third protein, designated the invariant polypeptide or Ii, which is basic in character and appears to be nonpolymorphic, specifically co-immunoprecipitates with Ia molecules. 2 McKean and his coworkers (22) have recently demonstrated that the interaction of this protein with Ia molecules is not an artifact of the isolation procedures. Proteins that appear to be the counterparts of Ii have been recognized in man and the rat (23, 24) .
In this paper, we investigate the relation of this invariant protein to the polypeptides that we have previously partially characterized and we extend our genetic mapping studies of the Ia polypeptides. We show that Ii does co-immunoprecipitate with our Ia molecules, that the strength of its interaction with Ia polypeptides varies with haplotype, and that it is not a precursor of the A,, Ap, E~, or E# polypeptides. We also demonstrate that the polypeptides we have previously characterized are contaminated with very little, if any, invariant protein. Further, we have used our HPCL tryptic peptide map technique to formally map the genes encoding the A,, Ap, and E# polypeptides to the I-A subregion using recombinant and F1 hybrid mice.
Materials and Methods
Mice. All mice used were obtained from the mouse colonies of Drs. McDevitt and Frelinger. Antisera. Monoclonal anti-A k antibodies were derived from the hybridoma cell line 10-2.16 (The Sulk Institute, San Diego, Calif.). The following atloantisera were used: A.TL anti-A.TH (A~), C3H anti-C.SW (A~), and B10XHTI)F1 anti-B10.A(3R) (Ek). Their specificities have been discussed previously (16, 17, 19) .
Isolation of Ia Antigens
RADIOLABELING. The procedures for radiolabeling and isolating Ia antigens have been described in detail elsewhere (16) . Briefly, splenic lymphocytes at a contzentration of 5 × 107 cells/ml (including erythrocytes) were cultured for 5-9 h in Hanks' balanced salt solution with 10 mM Hepes, 5% dialyzed fetal calf serum, and radiolabeled amino acids (New England Nuclear, Boston, Mass.). The cells were lysed at the same concentration with TST buffer (0.01 M Tris, 0.15 M NaCI, pH 7.3, and 0.5% Triton X-100) and, after centrifugation, the supernate (cell lysate) was stored at -70°C.
IMMUNOPRECIPITATION. Antigen-antibody complexes were isolated using formalin-fixed Staphylococcus aureus Cowan I strain (SAC) as described by Cullen and Schwartz (25) . The radiolabeled Ia antigens were eluted from the SAC by boiling for 2 rain in "elution" buffer (0.063 M Tris, pH 6.8, 2% 2-mercaptoethanol, and 2% SDS). In studies involving immunoprecipitation in the presence of 0.5% SDS, the washing buffer was TST buffer containing 0.1% SDS.
ONE-mMENSIONAL 0D)-SDS-PAGE. Radiolabeled Ia polypeptides in elution buffer (100-300 gl) were separated on 10% polyacrylamide gels (26) and were eluted from 1-mm gel slices using 0.0i% SDS. In duaMabel studies, aH and ~S dpm were calculated directly by a Beckmann Lsg000 scintillation counter (Beckman Instruments, Inc,, Fullerton, Calif.), using experimentally determined quench curves~ This polypeptide has been alternatively designated A, (40) because it is encoded by a gene located within the I-A subregion.
HPLC T(yptic Peptide
Mapping. The procedure used is essentially that described by McMillan et al. (18) . Each polypeptide was mixed with 0.25 mg porcine immunoglobulin and lyophilized. The protein was then reduced, alkylated, and digested with L(tosylamide-2-phenyl)-ethylchloromethyl-ketone(TPCK)-trypsin (Worthington Biochemical Corp., Freehold, N.J.), and the resulting tryptic peptides were analyzed by HPLC using either a 25-cm Zorbax-CN column (DuPont Instruments, Wilmington, Del.; Figs. 5-7 and 9) or a 25-cm Zorbax-ODS column (Fig. 8) at 49°C, and a phosphate/acetone solvent system. 0.5-ml fractions were collected every 30 s.
Two-Dimensional (2I)) Electrophoresis
The samples were loaded at the anode and separated in the first dimension by isoelectric focusing (IEF) and in the second dimension by SDS-PAGE. This is a modification of the methods described by O'Farrell (27, 28) .
Fms'r mMENSlON. The IEF gel mixture was made as follows: 0.8 ml twice-distilled water, 1.0 ml 10% (vol/vol) Triton X-100 solution, 0.84 ml stock acrylamide solution (100 ml contained 28.38 g acrylamide, 1.62 g bisacrylamide [Bio-Rad Laboratories, Richmond, Calif.]) and LKB ampholines (200 #1, pH 3.5-10; 70 #1, pH 9-11; 70 #1, pH 2.5-4) were added to 2.75 g urea. 8.5 #I ammonium persulfate and 6.3 /~I N,N,N',N'-tetramethylethylenediamine were used for polymerization. The solution was overlayed using 8 M urea and "lysis" buffer (9.5 M urea, 2% Triton X-100, 1.6% ampholines, pH 5-7, 0.4% ampholines, pH 3.5-10, and 5% 2-mercaptoethanol). After 2 h, the overlay solution was removed and, without 'prefocusing' each sample (in lysis buffer), was loaded at the anode and overlayed with 10 #1 of a solution containing 8 M urea, ampholines (0.2% pH 3.5-10, 0.8% pH 5-7), and 0.5 mg/ml each glutamic and aspartic acids. The samples were subjected to IEF at 500 V for 10-12 h. The gels to be analyzed in a second dimension were extruded into a solution containing 0.18 M Tris, pH 6.8, 30% glycerol, 7% SDS, and 12.5% 2-mercaptoethanol.
SECOND mMENSION. The IEF gels were sealed on top of the stack of an SDS slab gel (10% polyacrylamide) and electrophoresed as described by O'Farrell (27) . The gels were prepared for fluorography using the method of Bonner and Laskey (29) and were then dried and exposed to preflashed Kodak XR-5 film (Eastman Kodak Co., Rochester, N. Y.; 30).
METHIONINE pEPTIDE MAPS OF THE INVARIANT POLYPEPTIDE. The A s and E k molecules were sequentially immunoprccipitated from a [35S]mcthioninc-labclcd B 10.HTT cell lysatc and run on ID-SDS-PAGE. The proteins of ~31,000 tool wt (intermediate between a and fl) were mixed with carrier, reduced, alkylatcd, and precipitated with trichloroacctic acid (TCA). The precipitates were dissolved in lysis buffer and subjected to IEF. The gels were sliced into 2-ram discs and incubated in 0.5 ml containing 0.05 M ammonium bicarbonate and 0.05% SDS. 10% aliquots were counted, and the remaining 90% of the relevant fractions wcrc mixed with 0.25 nag porcine gammaglobulin that had bccn previously reduced and alkylated. After TCA precipitation, the proteins were digested with trypsin, and the pcptides were mapped using HPLC.
Results

I D-SDS-PAGE Analyses of aSS -and all-labeled Ia
Immunoprecipitates. In our characterizations of Ia polypeptides by partial amino acid analyses and HPLC tryptic peptide mapping, we had previously used tritiated amino acids. In contrast, in the 2D electrophoresis studies by Jones (31) and others (32) , [aSS] methionine was often used to facilitate analysis by autoradiography. To compare both types of incorporation, we labeled B10.A(1R) and B10.HTT spleen lymphocytes with [SH]phenylalanine and [aSS]methionine. Conventional immunoprecipitation in TST buffer using anti-Ia serum, followed by analysis on 1D-SDS-PAGE, gave the profiles shown in Fig. 1 , panels i and iii. The Aa and At~ polypeptides that we have previously isolated are the predominant species in the 3H-labeled immunoprecipitate, whereas a third species, having an apparent molecular weight intermediate between the a and fl polypeptides, is the dominant species when [a~S]methionine is used as radiolabel. We have confirmed that this is the invariant polypeptide, first described by Jones et al. (21), by our 2D gel analyses reported later in this paper. In all our [~S]methionine-labeled Ia immunoprecipitates (both A and E), we find that this polypeptide is always present and always appears to be the predominant species.
To determine whether the binding of this invariant protein to Ia molecules is as strong as the association between the a and fl polypeptides, immunoprecipitations were carried out in the presence of 0.5% SDS. Such conditions have been reported to dissociate actin from transplantation antigens (33) . 
2I) Electrophoretic Analyses of Ia Molecules and Isolated Ia Polypeptides. To determine
whether the invariant protein is a contaminant of any of the Ia polypeptides that we have partially sequenced or peptide mapped, we isolated polypeptides from preparative 1D-SDS-PAGE gels by our usual method, submitted them individually to 2D electrophoresis, and compared them to a 2D analysis of the appropriate total Ia immunoprecipitate. Fig. 2 shows the fluorographs of the 2D gels obtained from niland 35S-labeled total immunoprecipitates of the A s and E k molecules. Small fractions of the immunoprecipitates were also submitted both to analytical SDS-PAGE and IEF, and the distribution of radiolabel was determined by scintillation counting. The familiar radioactivity profiles obtained from 1D-SDS-PAGE gels are illustrated on the right in Fig. 2 and show a 3~S-rich peak, Ii, lying between the Ia polypeptides. The IEF radioactivity profiles, shown above the appropriate fluorograph, demonstrate that the aSS-rich polypeptide has a pI of ~8, and is the same for the A 8 and E k molecules. partial amino acid sequences were reported by McMillan et al. (17) . The invariant polypeptide was absent from both samples. Panels ii and iii show the analyses of isolated SH-and ~S-labeled A], A~, E~, and E~ polypeptides. They were isolated initially from 1D-SDS-PAGE gels in a manner identical to that used for our H P L C tryptic peptide mapping. Only A~ and E~ show slight contamination with the invariant polypeptide. Panel iv shows the result of analyzing all the radioactivity of molecular weight intermediate between the Ia polypeptides for both the A and the E immunoprecipitates. A large amount of invariant polypeptide is present in each. Peptide m a p p i n g of the acidic polypeptide in the left panel showed that its tryptic peptides eluted in a manner identical to those of the A] polypeptide, which we have previously characterized (panel ii). Because this polypeptide is more basic and smaller in molecular weight than A~, we conclude that it is probably an incompletely processed a-chain lacking some (or all) of its carbohydrate moietie(s). By analogy, in gel iv, the acidic polypeptide in the right panel is smaller in size and slightly more basic than the E~ polypeptide (panel iii), which suggests that it is an incomplete form of the E~ polypeptide. In Fig. 4 , the schematic diagrams depict portions of the 2D gels in Fig. 2 and summarize the results shown in Fig. 3 .
Comparative HPLC T~yptic Peptide Mapping on [aH]phenylalanine-labeled Polypeptides Isolated by ID-SDS-PAGE.
Having ascertained that the proteins we have partially chemically characterized contain little or no invariant polypeptide, we have used HPLC to analyze the radiolabeled tryptic peptides derived from Ia polypeptides and have genetically mapped the loci encoding the A~, A•, and E~ chains. Similar experiments have been reported by other laboratories (34) (35) (36) (37) (38) in which tryptic peptides were analyzed using ion-exchange chromatography and IEF.
One of the major advantages of HPLC over conventional ion-exchange chromatography is that its extreme reproducibility enables us to compare many peptide maps run over a period of several weeks. In contrast, only two polypeptides analyzed as a mixture, one a4C-labeled, the other ~H-labeled, can be compared by ion-exchange chromatography.
In this study, we have used [~H]phenylalanine as the radiolabel for three reasons: (a) phenylalanine can be obtained with high specific activity (often >I00 Ci/mM), (b) it is readily biosynthetically incorporated into Ia polypeptides, and (c) it is a more common amino acid than tyrosine and less common than leucine. In this way, we hoped to observe more tryptic peptides than in our previously reported studies using [3H]tyrosine; however, we did not wish to obtain too many peptides in case small differences in peptides were obscured by the overlapping of too many peptides, e.g., the E~ polypeptide has 7 tyrosine-, 15 leucine-, and 9 phenylalanine-labeled tryptic peptides.
In this peptide map study, we radiolabeled with a single amino acid (usually phenylalanine) because we wished to compare the tryptic maps of Ia polypeptides. Using this method, small differences in two very similar polypeptides can be demonstrated if radiolabeled peptides are involved. On the other hand, small dissimilarities may go undetected if the structural diversity resides only in unlabeled peptides. Nevertheless, this approach, using a single amino acid as label, is less complex than incorporating several radiolabeled amino acids simultaneously into Ia proteins. We have observed that the efficiency of biosynthetic incorporation of radiolabels into Ia polypeptides varies both with the individual mouse used and the particular batch of amino acid; moreover, the relative specific activities of amino acids vary between batches. Therefore, to avoid the necessity of an independent control to measure the relative incorporation of different amino acids into different lymphocytes, we chose to label each preparation with only one amino acid. Fig. 5 shows the phenylalanine-labeled tryptic peptide maps obtained for A~ and At~ polypeptides. Figs. 6 and 7 show the peptide maps used to map the Et~ polypeptides.
HPLC Mapping of Polypeptides Isolated by 1D-SDS-PAGE and IEF. To determine whether the invariant protein is structurally related to the Ia polypeptides, we compared the [~SS]methionine-labeled and the [3H]phenylalanine-labeled peptide maps of A~, A~, EL, and E~ with those of Ix.
The procedure for isolating the Ii protein is more complex than for isolating the A,, A~, E~, and EO polypeptides, which can be obtained directly from 1D-SDS-PAGE gels. The slices of SDS gels containing the invariant polypeptide are contaminated with an acidic polypeptide (probably incompletely processed forms of A~ and E~; see 35 HPLC tryptic peptide maps of [ S]methionine-labeled invariant polypeptides isolated from a B10.HTT cell lysate by immunoprecipitation, using anti-A 8 (left) and anti-E k sera (right). The polypeptides were separated using SDS-PAGE and IEF. Radioactivity is plotted on each ordinate, the fraction number is plotted on the abscissae. The organic solvent gradient is the same as that used for the A,, peptide maps. peptides are separated by the column, whereas in the maps ofA~, Ap, E~, and E~, only 2-3 methionine-labeled peptides are obtained. In contrast, in the [3H]phenylalaninelabeled tryptic peptide maps, the invariant protein possesses only two labeled peptides, whereas the Ia polypeptides yield 9-11 labeled peptides. Based on this evidence, we conclude that Ii is not a precursor of the A~, At~ , E=, and E~ polypeptides, and that none of the A~, A~, E~, or E~ polypeptides is a precursor of Ii. (21) , is always isolated under the normal immunoprecipitating conditions described by Cullen and Schwartz (25) . Under partially denaturing conditions (0.5% SDS), however, the association of Ix with A s molecules is much stronger than with A k molecules.
Discussion
The amino acid composition of the invariant polypeptide is unusual. It has at least eight methionine-labeled tryptic peptides, in contrast to the Ia polypeptides, which have 2-3 methionine-labeled peptides (a more common number for proteins in the 30,000-mol wt range). The Ii polypeptide has only two phenylalanine-labeled tryptic peptides, compared to the 9-11 labeled peptides obtained from the Ia polypeptides, and as judged from its pI (~8), it also has numerous lysine and/or arginine residues. It is not surprising, therefore, that our peptide map studies demonstrate that the invariant polypeptide is not a precursor of any Ia polypeptide, A~, Ap, E~, or E~.
The significance of the interaction of the invariant polypeptide with Ia molecules is not understood at present, but it may play an as yet undefined physiological role in the functioning of Ia molecules in the immune response. To date, experimental evidence suggests that Ii is not polymorphic and, therefore, no conclusions can be drawn about the chromosomal location of the gene encoding the invariant polypeptide. recently been defined by the proliferative response of the A.TL strain in mixed lymphocyte reactions (39) . Our peptide map data on the A.TL Ia molecules show that both the A~ and Ap polypeptides appear identical to those of the H-2 k haplotype and, therefore, the genes encoding them must map to the I-A and not the I-N subregion.
The Genes Encoding the Ia Polypeptides Have Been Mapped Using HPLC Comparative T~yptic Peptide Analyses
Several laboratories have reported that the gene encoding the Et~ polypeptide maps the I-A subregion, which agrees with our data (34-36, 38, 40) . In Fig. 6 , the peptide map of E~ from B10.A(5R) differs from those of B10.A(1R) and A.TL (which are identical to each other), and from those of B10.HTT and B10.S(9R) (which also are indistinguishable from one another). Thus, E a varies depending on the haplotype of the I-A and not the I-E subregion. To formally prove the gene encoding E a lies in the I-A subregion, we have also examined the structure of the E~ polypeptide in strains having the same I-A subregion (LA b) but differing in the origin of their I-E subregions (I-E k and LEa). Because of the lack of a recombinant mouse having an I-AbE a haplotype, we have used an F1 hybrid mouse having the H-2 bid haplotype. This Fa mouse would be expected to express on its cell surface the hybrid Ia molecules, E~Ead d + E~E~d b (38, 40, 41) . Our experiment is designed to answer the following d b question: is this E~ polypeptide in the E~Ea molecule the same as or different from the E~ polypeptide in a B10.A(5R) mouse (Ek~E~)? Fig. 7 shows that these two polypeptides are, in fact, identical, and formally proves that the E~ polypeptide is encoded by a gene mapping to the I-A subregion.
THe GENE ENCODING THE E~ POLYPEPTIDE MAPS TO THE I-E SUBREGION. Because the Ia molecules, E~Ea, are immunoprecipitated using anti-E subregion reagents, the E~ polypeptide must map to the I-E subregion, as the E a polypeptide maps to the I-A subregion. Although 2D electrophoresis studies by Jones (31) indicate that E d differs from E k, we found no detectable differences between the [3H]phenylalanine-labeled peptide maps of E~ and EL from B10.D2 and B 10.A(5R) strains. This agrees with the data of Silver et al. (42) , who analyzed the peptides using IEF. Cook et al. (14) report 93% identity of tryptic peptides when multiple amino acids are used as radiolabels.
The E~ Polypeptides of the 1-1-2 k'b" Haplotypes Are More Chemically Similar to Each Other than to the E# Polypeptides of the H-2 a Haph,type. Fig. 6 illustrates that the EO polypeptide from B10.A(5R), BI0.A(IR), A.TL, BI0.HTT, and BI0.SOR) have all but one of their phenylalanine-containing peptides in common (8 out of 9), and that each haplotype appears to have one unique peptide per haplotype (shaded black). Because peptide mapping tends to exaggerate differences between homologous proteins, this means that the E~ ~'b polypeptides are very similar; in fact, the E~ and E~ chains are indistinguishable by 2D electrophoresis, although they are chemically distinct by peptide mapping. In contrast, the E~ chain shares only 6 our of 9 of its phenylalaninelaheled peptides with the E~ '~'b polypeptides (Fig. 7) , which agrees with our previous studies using tyrosine* and [eucine-labeled proteins (18) .
This observation correlates beautifully with the observations of Lerner et al. (43), who have made a monoclonal antibody that reacts with Ia molecules composed of E~ and E~ 'b", but not E, and E~. It also is consistent with the serological work on Ia hybrid molecules of Lafuse et a]. (44) , who have shown that E~ and E~ share, together with E~, the determinant defining the specificity Ia.22. The E~ 'b'~ polypeptides do not express specificity Ia.23, which resides on the E~ chain.
E B Polypeptides in Ia Hybrid Molecules in F1
Mice Turn Over at Different Rates. Fig. 7 illustrates that in the peptide map of the H-2 bxa mouse the ratio of peptides unique to E~ compared to those unique to E~ is not the 1:1 ratio that would be expected assuming simple gene-dosage effects. The E~ polypeptide is more biosynthetically labeled than the E~ chain, and we have confirmed this observation independently by 2D electrophoresis, which showed that the E,~ spot was much more intense than the E~ spot. This differential labeling is not due to differences in the phenylalanine content of these proteins, because E~ and E~ are highly homologous polypeptides, sharing 66% of their phenyialanine-Iabeled tryptie peptides and having at least 7 out of 8 identical residues in their partial N-terminal amino acid sequences (17) .
Recently, Emerson et al. (45) have studied the biosynthesis and turnover of the EB polypeptides in homozygous (H-2 k) mice. They find that whereas the E~ chains are synthesized more rapidly than E, chains, the E,Ea molecules, once assembled, turn over at the same rate.
We should stress that experiments involving biosynthetic labeling cannot address questions involving the total amount of Ia protein expressed by a cell. However, these intriguing observations on the differential labeling of Et~ polypeptides in F1 mice, together with the observations of Emerson et al., underline the fact that the control of synthesis of Ia molecules may itself be complex and could possibly be haplotypedependent.
Thus, the role that Ia molecules play in immune responsiveness may depend not only on structural polymorphism and the diversity that can be generated by hybrid molecules, but also on the rate at which these molecules can be synthesized and turned over. New insights into this problem will undoubtedly be obtained when the Ia genes themselves can be examined and their regulatory mechanisms are investigated.
